Quantapore
17 employees
Biotech/Pharma
Series C · $50.5M
Open positions (1)
Company details
Team Size17
IndustryBiotech/Pharma
Funding
Total raised
$50.5M
Last stage
Series C
Investors
Fusion Fund
Total raised
$50.5M
Last stage
Series C
Investors
Martin Huber
Ph.D. in Genetics and Biochemistry from the University of Vienna. Over 20 years of experience in biotech startups in Europe and the US. Served as founder, CTO, and ultimately CEO of Quantapore. Previously held senior scientist positions at Ion Torrent and Nanosphere. Later joined Nautilus Biotechnology as VP of Biochemistry and Flow Cell Development.
Sascha C. Dennstedt
Co-founder of Quantapore and founder of at least one other company.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.